Insulin Receptor Substrate-2 Deficiency Impairs Brain Growth and Promotes Tau Phosphorylation

Markus Schubert(Howard Hughes Medical Institute), Derek P. Brazil(Harvard University), Deborah J. Burks(Howard Hughes Medical Institute), Jake A. Kushner(Joslin Diabetes Center), Jing Ye(Harvard University), Carrie L. Flint(Joslin Diabetes Center), Janet Farhang-Fallah(Harvard University), Pieter Dikkes(Howard Hughes Medical Institute), Xavier M. Warot(Joslin Diabetes Center), Carlos Río(Howard Hughes Medical Institute), Gabriel Corfas(Harvard University), Morris F. White(Joslin Diabetes Center)
Journal of Neuroscience
August 6, 2003
Cited by 487Open Access
Full Text

Abstract

Insulin resistance and diabetes might promote neurodegenerative disease, but a molecular link between these disorders is unknown. Many factors are responsible for brain growth, patterning, and survival, including the insulin-insulin-like growth factor (IGF)-signaling cascades that are mediated by tyrosine phosphorylation of insulin receptor substrate (IRS) proteins. Irs2 signaling mediates peripheral insulin action and pancreatic beta-cell function, and its failure causes diabetes in mice. In this study, we reveal two important roles for Irs2 signaling in the mouse brain. First, disruption of the Irs2 gene reduced neuronal proliferation during development by 50%, which dissociated brain growth from Irs1-dependent body growth. Second, neurofibrillary tangles containing phosphorylated tau accumulated in the hippocampus of old Irs2 knock-out mice, suggesting that Irs2 signaling is neuroprotective. Thus, dysregulation of the Irs2 branch of the insulin-Igf-signaling cascade reveals a molecular link between diabetes and neurodegenerative disease.


Related Papers

No related papers found

Powered by citation graph analysis